LAMISIL AT Trademark

Trademark Overview

On Tuesday, February 16, 1999, a trademark application was filed for LAMISIL AT with the United States Patent and Trademark Office. The USPTO has given the LAMISIL AT trademark a serial number of 75638238. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, August 19, 2020. This trademark is owned by Novartis AG. The LAMISIL AT trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, an antifungal
lamisil at

General Information

Serial Number75638238
Word MarkLAMISIL AT
Filing DateTuesday, February 16, 1999
Status800 - REGISTERED AND RENEWED
Status DateWednesday, August 19, 2020
Registration Number2466269
Registration DateTuesday, July 3, 2001
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 9, 1999

Trademark Statements

Goods and Servicespharmaceutical preparations, namely, an antifungal

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, March 27, 1999
Primary Code005
First Use Anywhere DateMonday, October 4, 1999
First Use In Commerce DateMonday, October 4, 1999

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBasel 4002
CH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Wednesday, August 19, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, August 19, 2020REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Wednesday, August 19, 2020REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, August 19, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 6, 2020TEAS SECTION 8 & 9 RECEIVED
Friday, July 3, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, November 10, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 10, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 21, 2010REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, July 21, 2010REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, July 15, 2010TEAS SECTION 8 & 9 RECEIVED
Tuesday, January 22, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 7, 2006REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, October 3, 2006REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, October 3, 2006REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, October 3, 2006REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, October 10, 2006CASE FILE IN TICRS
Tuesday, October 3, 2006TEAS SECTION 8 & 15 RECEIVED
Tuesday, October 3, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 3, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 3, 2001REGISTERED-PRINCIPAL REGISTER
Tuesday, March 13, 2001ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, March 12, 2001ASSIGNED TO EXAMINER
Monday, March 12, 2001ASSIGNED TO EXAMINER
Monday, March 5, 2001STATEMENT OF USE PROCESSING COMPLETE
Monday, January 22, 2001USE AMENDMENT FILED
Thursday, August 17, 2000EXTENSION 1 GRANTED
Thursday, June 29, 2000EXTENSION 1 FILED
Tuesday, February 1, 2000NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 9, 1999PUBLISHED FOR OPPOSITION
Friday, October 8, 1999NOTICE OF PUBLICATION
Wednesday, July 21, 1999APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 19, 1999ASSIGNED TO EXAMINER

Related Keywords

lamisil antifungal namely preparations pharmaceutical